Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Stephen J. Tomlanovich, MD
|
|
Give Review
Stephen Tomlanovich practices Internal Medicine. He researched medicine at University of Michigan Medical School. He has 2 awards "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dr. Stephen J. Tomlanovich is a published doctor and has 68 publications published. The lastest was: 'The role of tacrolimus in adult kidney transplantation: a review.' Stephen Tomlanovich accepts Medicare payments and is listed with Medicare.gov.
Publications
- Ciprofloxacin Prophylaxis in Kidney Transplant Recipients Reduces BK Virus Infection at 3 Months but not at 1 Year.
- Critical care of the end-stage liver Disease patient awaiting liver transplantation.
- Inguinal herniation of a transplant ureter.
- Long-term renal function and cardiovascular disease risk in obese Kidney donors.
- Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in Renal transplan...
- Sirolimus: defining nephrotoxicity in the Renal transplant recipient.
- Impact of sirolimus on early graft function after deceased-donor Kidney transplantation.
- Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
- Cyclosporin A and prednisolone: an additive inhibitory effect of cell proliferation and interleukin-2 production.
- Determination of blood flow to the transplanted Kidney. A novel application of phase-contrast, cine magnetic resonance imaging.
- The long-term course of cyclosporine-associated Chronic nephropathy.
- Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration.
- Transplant glomerulopathy as a cause of late graft loss.
- Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-Kidney transplantation--a case report.
- Renal transplantation in adults With autosomal recessive inheritance of hemolytic uremic syndrome.
- Cyclosporine-induced Chronic nephropathy in human recipients of cardiac allografts.
- The effects of ketoconazole on the intestinal Metabolism and bioavailability of cyclosporine.
- Cyclosporine-induced hemolytic uremic syndrome in a Heart transplant recipient.
- Combined Doppler and morphologic sonographic evaluation of Renal transplant rejection.
- Pharmacokinetics of orally and intravenously administered cyclosporine in pre-Kidney transplant patients.
- Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and Renal function.
- Determination of soluble IL-2 receptors in Kidney graft recipients--a 6-month follow-up.
- Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in Kidney transplant patients.
- How to improve results for second Renal allografts.
- Donor-specific blood transfusions versus cyclosporine--the DST story.
- Pharmacokinetics of mycophenolate mofetil and intravenous ganciclovir alone and in combination in Renal transplant recipients.
- Immunopharmacodynamic studies of cyclosporine in patients awaiting Renal transplantation.
- Rescue therapy With mycophenolate mofetil. Mycophenolate Mofetil Renal Refractory Rejection Study Group.
- Mycophenolate mofetil in Renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The Int...
- Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of Renal transplant re...
- Effect of cyclosporine on the clinical course of HBsAg-positive Renal transplant patients.
- The risk of transmission of Hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
- Cardiorespiratory fitness in pancreas-Kidney transplant recipients.
- Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver Kidney transplants at one to six months.
- Prednisone withdrawal in Kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
- Immunologic alterations induced by donor-specific transfusion.
- Pentoxifylline reduces the first-dose reactions following OKT3.
- Improved results With combined donor-specific transfusion (DST) and sequential therapy protocol.
- The incidence and impact of herpes simplex virus infections in the first month following Renal transplantation.
- Recurrent focal glomerulosclerosis: natural history and Response to therapy.
- Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
- Alterations in skeletal muscle structure are minimized With steroid Withdrawal after renal transplantation.
- Donor selection limits use of living-related liver transplantation.
- The role of tacrolimus in adult Kidney transplantation: a review.
- Acute renal allograft dysfunction secondary to suprarenal arterial stenosis: a case series and review of the literature.
- Standard sequential immunosuppression With Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity.
- Is cyclosporine effective in preventing recurrence of immune-mediated glomerular Disease after renal transplantation?
- Successful management of the highly sensitized Renal allograft recipient.
- Cyclosporine provides better success rates for both higher- and lower-risk cadaveric Kidney transplant recipients.
- Cytokine and T cell receptor gene expression at the site of allograft rejection.
- The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver Renal allograft recipients.
- Selection strategies for successful utilization of less than 15.kg pediatric donor Kidneys.
- Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of Acute rejection.
- Long-term outcome in Kidney transplant patients with hepatitis C (HCV) infection.
- Living donor Kidney transplant recipients and clinical trials: participation profiles and impact on post-transplant care.
- Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor Kidneys--long term experiences with 40 transplants.
- Health-related fitness and quality of life following steroid Withdrawal in renal transplant recipients.
- Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.
- Exercise capacity and muscle structure in Kidney recipient and twin donor.
- Sirolimus prolongs recovery from delayed graft function after cadaveric Renal transplantation.
- Conversion of stable Renal allograft recipients to a bioequivalent cyclosporine formulation.
- Successful long-term outcomes using pediatric en bloc Kidneys for transplantation.
- Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable Renal allograft recipients.
- A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor Kidney transplantation.
- Increased rejection in living unrelated versus living related Kidney transplants does not affect short-term function and survival.
- Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens.
- Early graft function after living donor Kidney transplantation predicts rejection but not outcomes.
Schools
University Of Michigan Medical School
Rush Presby St Lukes Med Ct
Henry Ford Hospital
Stanford University
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
- Internal Medicine
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Henry Ford Hospital - Wayne State University -
Rush University Medical Center -
University of Michigan Medical School
Hospital
-
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1528022670 | |
| NPPES Provider LastName | TOMLANOVICH | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 2088.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 28.0 | |
| Percent Opioid Claims | 1.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528022670 |
| Last Name Of The Provider | TOMLANOVICH |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
|
Dr. Christine C. Welles, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard M. Gerber, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nikola S. Bukurov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William S. Andereck, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Pragya Jain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa S. Law, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah A. Chiarucci, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Wojciechowski, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prescott G. Woodruff, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Leonid V. Yankulin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Irina Dukhovny, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian K. Lee, MD
This Doctor is OpenDoctor Recommended.
|